Advancing our science with bold humanity
As we pioneer our best-in-class B cell medicines and push to transform care for serious diseases, we never lose sight of the people at the center of our mission.
Eyes locked on the patient.
![](https://be.bio/wp-content/uploads/2023/11/illustrator-01.png)
![](https://be.bio/wp-content/uploads/2023/11/hero-photo-01.png)
![](https://be.bio/wp-content/uploads/2023/11/hero-photo-03.png)
![](https://be.bio/wp-content/uploads/2023/11/hero-photo-03.webp)
Our Science
Learn more about the work our team is doing to unleash the immense therapeutic possibilities of engineered B cell medicines.
Patients & Caregivers
Read more about how we are reimagining protein-based therapies to create freedom for people living with hemophilia B.
News
June 4, 2024
FDA Grants Orphan Drug Designation for BE-101, a Novel Engineered B Cell Medicine, for the Treatment of Hemophilia B
May 28, 2024